Armillariella Oral Solution Ameliorates Small Intestinal Damage in a Mouse Model of Chemotherapy-Induced Mucositis

References

• Zhan YS, Tan SW, Mao W, Jiang J, Liu HL, et al. Chemotherapy mediates intestinal injury via p53/p53 upregulated modulator of apoptosis (PUMA) signaling pathway. J Dig Dis 15, 425–434, 2014.
   PubMed Web of Science ®Google Scholar
• Zhu Q, He G, Wang J, Wang Y, and Chen W: Protective effects of fenofibrate against acute lung injury induced by intestinal ischemia/reperfusion in mice. Sci Rep 6, 22044, 2016.
   PubMed Web of Science ®Google Scholar
• Fu C, Chu J, Shen A, Liu L, Chen H, et al. Pien Tze Huang alleviates 5-fluorouracil-induced intestinal mucositis in CT-26 tumor-bearing mice. Exp Ther Med 14, 2291–2297, 2017.
   PubMed Web of Science ®Google Scholar
• Liu Z, Xie W, Li M, Teng N, Liang X, et al. Oral administration of polaprezinc attenuates fluorouracil-induced intestinal mucositis in a mouse model. Basic Clin Pharmacol Toxicol 121, 480–486, 2017.
   PubMed Web of Science ®Google Scholar
• Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100, 1995–2025, 2004.
   PubMed Web of Science ®Google Scholar
• Bowen JM, Gibson RJ, Cummins AG, and Keefe DM: Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support Care Cancer 14, 713–731, 2006.
   PubMed Web of Science ®Google Scholar
• Yasuda M, Kato S, Yamanaka N, Iimori M, Utsumi D, et al. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Am J Physiol Gastrointest Liver Physiol 302, G1133–G1142, 2012.
   PubMed Web of Science ®Google Scholar
• Peng J, Ding J, Tan C, Baggenstoss B, Zhang Z, et al. Oligomerization of membrane-bound Bcl-2 is involved in its pore formation induced by tBid. Apoptosis 14, 1145–1153, 2009.
   PubMed Web of Science ®Google Scholar
• Brittan M, and Wright NA: Stem cell in gastrointestinal structure and neoplastic development. Gut 53, 899–910, 2004.
   PubMed Web of Science ®Google Scholar
• Koo BK, and Clevers H: Stem cells marked by the R-spondin receptor LGR5. Gastroenterology 147, 289–302, 2014.
   PubMed Web of Science ®Google Scholar
• Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003–1007, 2007.
   PubMed Web of Science ®Google Scholar
• Gou H, Gu LY, Shang BZ, Xiong Y, and Wang C: Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice. Hum Exp Toxicol 35, 1243–1251, 2016.
   PubMed Web of Science ®Google Scholar
• Shi CJ, Wen XS, Gao HF, Liu ZH, Xu XK, et al. Steamed root of Rehmannia glutinosa Libosch (Plantaginaceae) alleviates methotrexate-induced intestinal mucositis in rats. J Ethnopharmacol 183, 143–150, 2016.
   PubMed Web of Science ®Google Scholar
• Sun D, Zhu L, Xiao L, Xia Y, Ge G, et al. In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences. Xenobiotica 44, 988–995, 2014.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Li P, Tang Y, Fawcett JP, et al. Quantitation of Armillarisin A in human plasma by liquid chromatography-electrospray tandem mass spectrometry. J Pharm Biomed Anal 43, 1860–1863, 2007.
   PubMed Web of Science ®Google Scholar
• Wu P, Guo Y, Jia F, and Wang X: The effects of Armillarisin A on serum IL-1β and IL-4 and in treating ulcerative colitis. Cell Biochem Biophys 72, 103–106, 2015.
   PubMed Web of Science ®Google Scholar
• You W, Zhang M, Li P, Zhang FL, Su L, and Xu YY: Protective effect of Armillariella oral solution on intestinal mucosal injury induced by cisplatin in mice. China J New Drugs 22, 2683–2687, 2013.
   Google Scholar
• Zhang T, Lu SH, Bi Q, Liang L, Wang YF, et al. Volatile oil from Amomi fructus attenuates 5-fluorouracil-induced intestinal mucositis. Front Pharmacol 8, 786, 2017.
   PubMed Web of Science ®Google Scholar
• Yasuda M, Kato S, Yamanaka N, Iimori M, Matsumoto K, et al. 5-HT(3) receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells. Br J Pharmacol 168, 1388–1400, 2013.
   PubMed Web of Science ®Google Scholar
• Xian CJ, Howarth GS, Mardell CE, Cool JC, Familari M, et al. Temporal changes in TFF3 expression and jejunal morphology during methotrexate-induced damage and repair. Am J Physiol 277, G785–G795, 1999.
   PubMedGoogle Scholar
• MacPherson BR, and Pfeiffer CJ: Experimental production of diffuse colitis in rats. Digestion 17, 135–150, 1978.
   PubMed Web of Science ®Google Scholar
• Takagi H, Azuma K, Tsuka T, Imagawa T, Osaki T, et al. Antitumor effects of high-temperature hyperthermia on a glioma rat model. Oncol Lett 7, 1007–1010, 2014.
   PubMed Web of Science ®Google Scholar
• Gibson RJ, and Stringer AM: Chemotherapy-induced diarrhoea. Curr Opin Support Palliat Care 3, 31–35, 2009.
   PubMedGoogle Scholar
• Hauer-Jensen M, Denham JW, and Andreyev HJ: Radiation enteropathy–pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol 11, 470–479, 2014.
   PubMed Web of Science ®Google Scholar
• Berbee M, and Hauer-Jensen M: Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?. Curr Opin Support Palliat Care 6, 54–59, 2012.
   PubMed Web of Science ®Google Scholar
• Yu J: Intestinal stem cell injury and protection during cancer therapy. Transl Cancer Res 2, 384–396, 2013.
   PubMed Web of Science ®Google Scholar
• Li X, Yang G, Li X, Zhang Y, Yang J, et al. Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in chinese. PLoS One 8, e60338, 2013.
   PubMed Web of Science ®Google Scholar
• Wang JJ, and Li P: Overview of research on armillarisin preparations. Clin J Trad Chin Med 22, 469–470, 2010.
   Google Scholar
• Al-Asmari AK, Khan AQ, Al-Qasim AM, and Al-Yousef Y: Ascorbic acid attenuates antineoplastic drug 5-fluorouracil induced gastrointestinal toxicity in rats by modulating the expression of inflammatory mediators. Toxicol Rep 2, 908–916, 2015.
   PubMed Web of Science ®Google Scholar
• de Avila PHM, de Avila RI, Dos Santos Filho EX, Cunha Bastos CC, Batista AC, et al. Mucoadhesive formulation of Bidens pilosa L. (Asteraceae) reduces intestinal injury from 5-fluorouracil-induced mucositis in mice. Toxicol Rep 2, 563–573, 2015.
   PubMed Web of Science ®Google Scholar
• Lee JM, Chun HJ, Choi HS, Kim ES, Seo YS, et al. Selenium administration attenuates 5-flurouracil-induced intestinal mucositis. Nutr Cancer 69, 616–622, 2017.
   PubMed Web of Science ®Google Scholar
• Mashtoub S, Lampton LS, Eden GL, Cheah KY, Lymn KA, et al. Emu oil combined with Lyprinol™ reduces small intestinal damage in a rat model of chemotherapy-induced mucositis. Nutr Cancer 68, 1171–1180, 2016.
   PubMed Web of Science ®Google Scholar
• Zhang J, Cai H, Sun L, Zhan P, Chen M, et al. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients. J Exp Clin Cancer Res 37, 225, 2018.
   PubMed Web of Science ®Google Scholar
• Zhan Y, Xu C, Liu Z, Yang Y, Tan S, et al. β-Arrestin1 inhibits chemotherapy-induced intestinal stem cell apoptosis and mucositis . Cell Death Dis 7, e2229, 2016.
   PubMed Web of Science ®Google Scholar
• Metcalfe C, Kljavin NM, Ybarra R, and de Sauvage FJ: Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell 14, 149–159, 2014.
   PubMed Web of Science ®Google Scholar